Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Glucocorticoid toxicity index

View through CrossRef
The Glucocorticoid Toxicity Index (GTI) is a glucocorticoid-related toxicity measurement tool which was recently developed by an international expert panel. GTI can be calculated with two different methods: Cumulative Worsening Score (CWS) and Aggregate Improvement Score (AIS). The total glucocorticoid-related toxicity during follow-up can be calculated with CWS. All parameters that develop over time continue to be included, and a decrease in the CWS is not possible. On the contrary, both increase and decrease in toxicity can be assessed in scoring with the AIS method. A drug that reduces glucocorticoid toxicity should be able to reduce the AIS score. Cumulative glucocorticoid dose was found to be associated with higher GTI scores in studies. Although not all glucocorticoid-related toxicities can be covered, parameters that are common, dynamic, and more likely to be glucocorticoid-related are included in GTI. GTI has some limitations such as the possibility of not detecting chronic damage, the difficulty in interpreting the score in the patients who have already sterted the glucocorticoid treatment, some parameters requiring direct interaction with the patient, and difficulty in calculation.
Hacettepe University - Medical School
Title: Glucocorticoid toxicity index
Description:
The Glucocorticoid Toxicity Index (GTI) is a glucocorticoid-related toxicity measurement tool which was recently developed by an international expert panel.
GTI can be calculated with two different methods: Cumulative Worsening Score (CWS) and Aggregate Improvement Score (AIS).
The total glucocorticoid-related toxicity during follow-up can be calculated with CWS.
All parameters that develop over time continue to be included, and a decrease in the CWS is not possible.
On the contrary, both increase and decrease in toxicity can be assessed in scoring with the AIS method.
A drug that reduces glucocorticoid toxicity should be able to reduce the AIS score.
Cumulative glucocorticoid dose was found to be associated with higher GTI scores in studies.
Although not all glucocorticoid-related toxicities can be covered, parameters that are common, dynamic, and more likely to be glucocorticoid-related are included in GTI.
GTI has some limitations such as the possibility of not detecting chronic damage, the difficulty in interpreting the score in the patients who have already sterted the glucocorticoid treatment, some parameters requiring direct interaction with the patient, and difficulty in calculation.

Related Results

Reduced enteric BDNF-TrkB signaling drives stress-dependent glucocorticoid-mediated GI dysmotility
Reduced enteric BDNF-TrkB signaling drives stress-dependent glucocorticoid-mediated GI dysmotility
Abstract Stress is a key contributor to gastrointestinal (GI) dysmotility, particularly in patients with disorders of gut-brain interactions (DGB...
BMI Is Not Associated with Toxicity to High Dose Methotrexate: A Single Institution Retrospective Study of 147 Patients
BMI Is Not Associated with Toxicity to High Dose Methotrexate: A Single Institution Retrospective Study of 147 Patients
Background: High-dose methotrexate (HD-MTX) with leucovorin rescue is frequently used in the treatment of various lymphomas, breast cancer, and sarcomas and remains ...
Hypoxia Inducible Factor 1α-driven steroidogenesis impacts systemic hematopoiesis
Hypoxia Inducible Factor 1α-driven steroidogenesis impacts systemic hematopoiesis
Abstract Glucocorticoids regulate hematopoiesis, but how chronic elevation of endogenous glucocorticoid production affects hematopoietic stem cel...
Glucocorticoid administration in antiemetic therapy
Glucocorticoid administration in antiemetic therapy
AbstractBACKGROUNDAlthough glucocorticoids are often used in cancer therapy, in particular to enhance the effectiveness of antiemetic therapy, they have been associated with impair...
The effect of vitamin 25-(OH)-D3 on Glucocorticoid Receptor-β (GRβ) and 25-(OH)-D receptors in idiopathic nephrotic syndrome patients
The effect of vitamin 25-(OH)-D3 on Glucocorticoid Receptor-β (GRβ) and 25-(OH)-D receptors in idiopathic nephrotic syndrome patients
Backgound: Idiopathic Nephrotic Syndrome (INS) is the most chronic glomerular disease in children. Glucocorticoid is the main therapy acts by binding to glucocorticoid receptor α (...

Back to Top